TABLE 2.
Circulating circRNAs as biomarkers of MI.
| CircRNA | Source | Regulation | Application | References |
|---|---|---|---|---|
| circRNA_081881 | plasma | down | Diagnostic biomarker | Deng et al. (2016) |
| MICRA | whole blood | ------ | prognostic biomarker for MI risk stratification | Salgado-Somoza et al. (2017) |
| peripheral blood | Down | Predictive biomarker of ventricular dysfunction in MI patients | Vausort et al. (2016) | |
| circRNA_104761 | whole blood | Down | Diagnostic biomarker | Yang et al. (2021) |
| hsa_circRNA_001654 | whole blood | Up | Diagnostic biomarker | Zhao et al. (2021b) |
| hsa_circRNA_405624 | whole blood | Up | Diagnostic biomarker | Zhao et al. (2021b) |
| hsa_circRNA_091761 | whole blood | Up | Diagnostic biomarker | Zhao et al. (2021b) |
| hsa_circRNA_406698 | whole blood | Up | Diagnostic biomarker | Zhao et al. (2021b) |